Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023

2022-12-13
OSLO, Norway, Dec. 13, 2022 /PRNewswire/ -- Nordic Nanovector ASA's ("Nordic Nanovector" or the "Company") largest shareholder North Energy ASA, that now holds 11,518,448 shares in the Company, has requested that the Board of Directors calls for an Extraordinary General Meeting in accordance with the Norwegian Public Limited Liability Companies Act §5-7 (2). The Board of Directors therefore calls for an Extraordinary General Meeting to be held on 3 January 2023, at 16:00 hours CET at Advokatfirmaet Selmer, Tjuvholmen Allé 1, 0252 Oslo. The full notice with appendices is attached. The notice and the documents to which it refers are also available on . The following matters will be on the agenda: Election of members to the Board of Directors Election of members to the Nomination Committee The Nomination Committee have not received further information on proposed members under the two items on the agenda and will expect North Energy ASA to do so in due course, and at the latest at the general meeting. Shareholders wishing to attend the Extraordinary General Meeting, in person or by proxy, must complete and return the attendance form or power of attorney form attached to the notice to Nordea Bank Abp, Issuer Service, Postboks 1166 Sentrum, N-0107 Oslo, or by e-mail to nis@nordea.com no later than 2 January 2023, 16:00 CET. Attendance or proxies may also be registered electronically through Euronext Securities Oslo (formerly VPS) Investor Services. For further information, please contact: IR enquiries Malene Brondberg, interim CEO and CFO Cell: +44 7561 431 762 Email: ir@nordicnanovector.com Media Enquiries Mark Swallow/Frazer Hall/David Dible (Citigate Dewe Rogerson) Tel: +44 203 926 8535 Email: nordicnanovector@citigatedewerogerson.com This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act. The following files are available for download: View original content: SOURCE Nordic Nanovector Company Codes: Bloomberg:NANOV@NO, ISIN:NO0010597883, Oslo:NANOV, RICS:NANOV.OL, Stockholm:NANOO
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。